BIO-key International Statistics
Share Statistics
BIO-key International has 3.13M shares outstanding. The number of shares has increased by 72.72% in one year.
| Shares Outstanding | 3.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 57.76% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.33M |
| Failed to Deliver (FTD) Shares | 704 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 865.18K, so 27.67% of the outstanding shares have been sold short.
| Short Interest | 865.18K |
| Short % of Shares Out | 27.67% |
| Short % of Float | 37.18% |
| Short Ratio (days to cover) | 0.16 |
Valuation Ratios
The PE ratio is -0.2 and the forward PE ratio is -0.71.
| PE Ratio | -0.2 |
| Forward PE | -0.71 |
| PS Ratio | 0.22 |
| Forward PS | null |
| PB Ratio | 1.58 |
| P/FCF Ratio | -0.44 |
| PEG Ratio | n/a |
Enterprise Valuation
BIO-key International Inc. has an Enterprise Value (EV) of 1.51M.
| EV / Earnings | -0.18 |
| EV / Sales | 0.2 |
| EV / EBITDA | -0.19 |
| EV / EBIT | -0.17 |
| EV / FCF | -0.4 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.31.
| Current Ratio | 0.82 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.31 |
| Total Debt / Capitalization | 23.54 |
| Cash Flow / Debt | -11.58 |
| Interest Coverage | -40.44 |
Financial Efficiency
Return on equity (ROE) is -8.01% and return on capital (ROIC) is -608.13%.
| Return on Equity (ROE) | -8.01% |
| Return on Assets (ROA) | -1.89% |
| Return on Capital (ROIC) | -608.13% |
| Revenue Per Employee | 180.35K |
| Profits Per Employee | -198.18K |
| Employee Count | 43 |
| Asset Turnover | 1.72 |
| Inventory Turnover | 14.19 |
Taxes
| Income Tax | -134.01K |
| Effective Tax Rate | 0.02 |
Stock Price Statistics
The stock price has increased by -27.75% in the last 52 weeks. The beta is 0.24, so BIO-key International 's price volatility has been higher than the market average.
| Beta | 0.24 |
| 52-Week Price Change | -27.75% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 51.35 |
| Average Volume (20 Days) | 2.42M |
Income Statement
In the last 12 months, BIO-key International had revenue of 7.75M and earned -8.52M in profits. Earnings per share was -15.21.
| Revenue | 7.75M |
| Gross Profit | 1.43M |
| Operating Income | -8.83M |
| Net Income | -8.52M |
| EBITDA | -7.85M |
| EBIT | -8.83M |
| Earnings Per Share (EPS) | -15.21 |
Balance Sheet
The company has 511.40K in cash and 365.35K in debt, giving a net cash position of 146.05K.
| Cash & Cash Equivalents | 511.40K |
| Total Debt | 365.35K |
| Net Cash | 146.05K |
| Retained Earnings | -125.01M |
| Total Assets | 6.40M |
| Working Capital | -1.32M |
Cash Flow
In the last 12 months, operating cash flow was -3.79M and capital expenditures -1K, giving a free cash flow of -3.79M.
| Operating Cash Flow | -3.79M |
| Capital Expenditures | -1K |
| Free Cash Flow | -3.79M |
| FCF Per Share | -6.77 |
Margins
Gross margin is 18.46%, with operating and profit margins of -113.82% and -109.89%.
| Gross Margin | 18.46% |
| Operating Margin | -113.82% |
| Pretax Margin | -111.62% |
| Profit Margin | -109.89% |
| EBITDA Margin | -101.19% |
| EBIT Margin | -113.82% |
| FCF Margin | -48.93% |
Dividends & Yields
BKYI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1102.17% |
| FCF Yield | -87.93% |
Analyst Forecast
Currently there are no analyst rating for BKYI.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 21, 2023. It was a backward split with a ratio of 1:18.
| Last Split Date | Dec 21, 2023 |
| Split Type | backward |
| Split Ratio | 1:18 |
Scores
| Altman Z-Score | -31.52 |
| Piotroski F-Score | 4 |